Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Phathom Pharmaceuticals (PHAT) Profit After Tax: 2018-2024

Historic Profit After Tax for Phathom Pharmaceuticals (PHAT) over the last 7 years, with Dec 2024 value amounting to -$334.3 million.

  • Phathom Pharmaceuticals' Profit After Tax rose 64.98% to -$30.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$274.6 million, marking a year-over-year increase of 19.12%. This contributed to the annual value of -$334.3 million for FY2024, which is 65.84% down from last year.
  • Latest data reveals that Phathom Pharmaceuticals reported Profit After Tax of -$334.3 million as of FY2024, which was down 65.84% from -$201.6 million recorded in FY2023.
  • Over the past 5 years, Phathom Pharmaceuticals' Profit After Tax peaked at -$129.1 million during FY2020, and registered a low of -$334.3 million during FY2024.
  • In the last 3 years, Phathom Pharmaceuticals' Profit After Tax had a median value of -$201.6 million in 2023 and averaged -$244.5 million.
  • In the last 5 years, Phathom Pharmaceuticals' Profit After Tax surged by 49.41% in 2020 and then tumbled by 65.84% in 2024.
  • Over the past 5 years, Phathom Pharmaceuticals' Profit After Tax (Yearly) stood at -$129.1 million in 2020, then declined by 11.48% to -$143.9 million in 2021, then slumped by 37.42% to -$197.7 million in 2022, then declined by 1.96% to -$201.6 million in 2023, then tumbled by 65.84% to -$334.3 million in 2024.